Crossmark

Absence of EIF1AX, PPM1D, and CHEK2 mutations reported in Thyroid Cancer Genome Atlas (TCGA) in a large series of thyroid cancer

Crossref DOI link: https://doi.org/10.1007/s12020-018-1762-6

Published Online: 2018-09-29

Published Print: 2019-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Alzahrani, Ali S.

Murugan, Avaniyapuram Kannan

Qasem, Ebtesam

Alswailem, Meshael M.

AlGhamdi, Balgees

Moria, Yosra

Al-Hindi, Hindi
License Information

Text and Data Mining valid from 2018-09-29
More Information

Article History

Received: 8 June 2018

Accepted: 11 September 2018

First Online: 29 September 2018

Change Date: 25 June 2019

Change Type: Correction

Change Details: The original version of this article unfortunately contained a mistake in the abstract and body of the article, the acronym TCGA should refer to “The Cancer Genome Atlas” not “Thyroid Cancer Genome Atlas”. This has been corrected with this erratum.

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: This study was performed only on archived pathology samples and did not obtain any new samples from the patients. With that and according to the Institutional Review Board rules and guidelines, informed consents were waived by the Institutional Review Board of the King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.